Design Therapeutics (DSGN) Equity Ratio (2020 - 2021)
Historic Equity Ratio for Design Therapeutics (DSGN) over the last 2 years, with Q3 2021 value amounting to 0.98.
- Design Therapeutics' Equity Ratio changed N/A to 0.98 in Q3 2021 from the same period last year, while for Sep 2021 it was 0.98, marking a year-over-year change of. This contributed to the annual value of 0.31 for FY2020, which is N/A changed from last year.
- Design Therapeutics' Equity Ratio amounted to 0.98 in Q3 2021.
- In the past 5 years, Design Therapeutics' Equity Ratio registered a high of 0.99 during Q2 2021, and its lowest value of 0.31 during Q4 2020.